Sunshine and rash: Testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Most patients who receive epidermal growth factor receptor (EGFR) inhibitors develop a rash. To date, no effective palliative therapy has been developed for these rashes. This review describes the rationale behind N05C4, a placebo-controlled trial of sunscreen as an intervention to prevent EGFR inhibitor-related rash.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalSupportive Cancer Therapy
Volume4
Issue number4
DOIs
StatePublished - Sep 2007

Keywords

  • Prevention
  • Squamous cell carcinoma
  • Ultraviolet light

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Cancer Research

Fingerprint Dive into the research topics of 'Sunshine and rash: Testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash'. Together they form a unique fingerprint.

  • Cite this